Mechanistically, we demonstrated that the loss of FBP1 expression in ovarian cancer was due to C-MYC-mediated promoter hypermethylation and that enhanced FBP1 directly interacted with STAT3 to inhibit its nuclear translocation and the subsequent activation of STAT3-regulated genes. Here, FBP1 is linked to ovarian carcinoma.